Compositions for making and using anti-Myostatin antibodies
US11925683B2 · kind B2 · utility
1Cited by
13References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2021 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Apr 3, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the present disclosure relate to antibodies that specifically bind proMyostatin and/or latent Myostatin and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.